(Q84015414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Andrew J. Currie

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

4

Bruce W S Robinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Amy C Prosser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ivonne van Bruggen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1617-1627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cutting edge: tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The Janus face of dendritic cells in cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cancer immunotherapy by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

On cross-priming of MHC class I-specific CTL: rule or exception?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Taking dendritic cells into medicine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The cell biology of cross-presentation and the role of dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CD8– dendritic cells preferentially cross-presentSaccharomyces cerevisiae antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The dendritic cell populations of mouse lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Antigen presentation by dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

T-cell recognition of melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Carcinoembryonic antigen (CEA) and other tumor markers in ovarian and cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Neutrophils efficiently cross-prime naive T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CpG-DNA aided cross-priming by cross-presenting B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Inhibitory B7-family molecules in the tumour microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

CD8alpha-11b+ dendritic cells but not CD8alpha+ dendritic cells mediate cross-tolerance toward intestinal antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Determination of lymphocyte division by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940153

7 January 2021

Identifiers

DOI

10.1002/EJI.200940153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20373290%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference